David Wolk of the Perelman School of Medicine outlines the key takeaways of new Alzheimer’s drug lecanemab.
https://bit.ly/3ZmnZML Philadelphia InquirerDavid Wolk of the Perelman School of Medicine outlines the key takeaways of new Alzheimer’s drug lecanemab.
https://bit.ly/3ZmnZML Philadelphia Inquirer